Humana Inc (HUM) · Oct 9, 2026 · Other events

Humana Medicare Advantage update clears 2028 Stars goal

Top Quartile achieved — BY28 Stars revenue PMPM exceeded the peer median by more than 10%

Humana’s Medicare Advantage ratings beat its Top Quartile target for 2028, creating a potential one-time benefit while 2026 EPS guidance stays unchanged.

Humana is rebuilding its Medicare Advantage earnings engine after a Star Ratings-driven 2026 headwind, with management’s longer-term plan centered on restoring Top Quartile performance by Bonus Year 2028. The ratings recovery arrived ahead of the key deadline. Based on final 2027 MA Star Ratings, Humana says it exceeded its Top Quartile goal, defined as Stars revenue per member per month at least 10% above the peer median. 〔0〕 That is more meaningful than simply improving from a weak base: it suggests the quality-bonus economics underpinning the 2028 recovery plan are now tracking above the company’s own target, not merely toward it.

ItemFiling detail
Top Quartile definitionStars revenue PMPM at least 10% above peer median
FY 2026 adjusted EPS guidanceAt least $9.00
Expected benefit timing2028, with some outperformance potentially one-time

This is a business-story upgrade, not a 2026 earnings raise. Humana reaffirmed adjusted EPS guidance of at least $9.00, which was already in place, so the immediate profit outlook is unchanged. The value is instead in improving the credibility of the 2028 earnings framework: stronger Stars performance can support higher rebates and quality payments, although the eventual dollar benefit still depends on membership, contract mix, risk scores, benchmarks, rebates, and competitive pricing.

The company is deliberately treating part of the upside as temporary. Humana says some BY28 outperformance versus Top Quartile will be one-time and expects to direct that benefit toward investments and shareholder returns, while warning that its GAAP EPS guidance may still change as strategic initiatives are completed. 〔1〕 The next substantive checkpoint is the December 10, 2026 investor update, when management plans to quantify how this ratings result fits into its 2028 earnings plan.

Bottom line: Humana has cleared the central quality hurdle in its recovery plan earlier and better than expected, but the filing does not increase 2026 earnings guidance. It materially strengthens the 2028 story while leaving the size and durability of the benefit to be quantified later.

What to watch next

December 10 investor update

Original filing on SEC EDGAR

More Humana Inc news

Humana Medicare Advantage update clears 2028 Stars goal | HUM Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.